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INTRODUCTION
It is likely that one in four adults in the UK 
have high blood pressure (BP), with deprived 
areas having the highest prevalence.1 There 
have been improvements in recent years, 
with the population average systolic BP 
falling by 3 mmHg over the past decade, 
and the proportion of adults with controlled 
hypertension increasing from 5% to 10% 
between 2003–2016.1 However, managing 
hypertension remains a significant burden 
on general practice and accounts for an 
estimated 12% of all visit to GPs in England.2 
Chronic disease management is 
shifting towards models of care that focus 
on patient centricity, supporting self-
management behaviours and improving 
care pathways with better integration of 
healthcare professional teams.3 In recent 
years there has been an increased focus on 
new models of care for the management 
of hypertension, often involving the 
patient more in the process. Studies have 
investigated using patients’ home BP 
readings to guide treatment, either by 
bringing them along to consultation or 
using technology to relay the information 
(telemonitoring).4,5 Other studies have 
investigated nurse or pharmacist-led 
medication titration.6,7 Further studies 
have included self-management whereby 
patients titrate their own medication 
according to a pre-arranged plan.8
The National Institute for Health and 
Care Excellence (NICE), which provides 
guidelines for use in England, released 
new draft guidelines for the management 
of hypertension in early 2019, and discuss 
the evidence of effectiveness for out-of-
office BP measurement, and pharmacist 
management of BP.2 The guidelines 
support home monitoring of BP, where 
patients are willing and motivated to do so, 
while stipulating that patients need to know 
how to measure their BP correctly, and 
when to contact healthcare professionals 
if they are not achieving their target BP. 
With the variety of potentially effective 
hypertension management options, it is 
important to determine how patients value 
different models of care, and the relative 
importance of factors in their decision-
making process. For the purposes of this 
study, a discrete choice experiment (DCE) 
was used to explore patient preferences for 
hypertension models of care in the UK: who 
measures BP, where this occurs, and who 
leads treatment changes. 
There has been an ongoing increase 
in the publication of health-related DCEs, 
from approximately 3 per year between 
1990–2000, to 45 per year between 2009–
2012, as they are becoming recognised as a 
useful method for accessing preference for 
services in health.9 A brief description of a 
DCE is presented in Box 1. 
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Abstract
Background
With a variety of potentially effective hypertension 
management options, it is important to 
determine how patients value different models 
of care, and the relative importance of factors in 
their decision-making process.
Aim
To explore patient preferences for the 
management of hypertension in the UK.
Design and setting
Online survey of patients who have hypertension 
in the UK including an unlabelled discrete choice 
experiment (DCE).
Method
A DCE was developed to assess patient 
preferences for the management of hypertension 
based on four attributes: model of care, 
frequency of blood pressure (BP) measurement, 
reduction in 5-year cardiovascular risk, and 
costs to the NHS. A mixed logit model was used 
to estimate preferences, willingness-to-pay 
was modelled, and a scenario analysis was 
conducted to evaluate the impact of changes in 
attribute levels on the uptake of different models 
of care.
Results
One hundred and sixty-seven participants 
completed the DCE (aged 61.4 years, 45.0% 
female, 82.0% >5 years since diagnosis). All four 
attributes were significant in choice (P<0.05). 
Reduction in 5-year cardiovascular risk was the 
main driver of patient preference as evidenced 
in the scenario and willingness-to-pay analyses. 
GP management was significantly preferred over 
self-management. Patients preferred scenarios 
with more frequent BP measurement, and lower 
costs to the NHS.
Conclusion
Participants had similar preferences for GP 
management, pharmacist management, and 
telehealth, but a negative preference for self-
management. When introducing new models of 
care for hypertension to patients, discussion of the 
potential benefits in terms of risk reduction should 
be prioritised to maximise uptake.
Keywords
general practice, hypertension, patient 
preference.
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METHOD
Identifying attributes and levels
A number of sources of information were 
used to inform the development and 
refinement attributes for inclusion in the 
DCE. Attributes were based on a literature 
review,10 expert opinion, and interviews with 
patients with hypertension; 11 participants 
(seven females, aged 50–86 years, 73% 
>5 years since diagnosis) were interviewed 
between November 2015 and March 
2016. Participants were recruited from 
two general practices in Oxfordshire, one 
serving a predominantly rural community 
and the other urban. Interviews were semi-
structured, followed a topic guide, and 
were recorded. Transcripts were analysed 
using a framework approach using NVivo 
(version 11). 
Four attributes were chosen for inclusion 
in the DCE, and the rationale for inclusion 
is as described below. Each of the four 
attributes had four levels and these are 
shown in Box 2.
Model of care. Model of care for 
hypertension can be thought of in terms 
of who measures BP (patient, nurse, 
pharmacist, or GP) and who is responsible 
for making medication changes in response 
to the latest BP measurements (GP or 
nurse/pharmacist/patient according to a 
prearranged agreement with GP). Varying 
these two factors resulted in 16 possible 
combinations. For this experiment it was 
decided to pick the default option (GP 
measurement and management) as well as 
three options that were realistic, actionable 
by policy, and have already been shown to be 
effective and acceptable interventions.
Frequency of BP measurement. Currently, 
it is recommended by NICE that patients 
with hypertension with well controlled 
BP are offered an annual review of their 
care, and therefore may only have their BP 
measured for that occasion.11 However, 30% 
of patients with hypertension currently visit 
their GP at least three times per year, with 
one in ten making more than five visits.12 
Reduction in 5-year cardiovascular 
risk. Epidemiological evidence at the time 
of this study suggested that the risk of 
cardiovascular disease rises with increasing 
BP starting at around 115/75 mmHg.13 A 
large number of clinical trials have shown 
that lowering systolic BP by 10 mmHg 
reduces risk of stroke by 35–40%, myocardial 
infarction by 20–25%, and heart failure by up 
to 50%.14 
Since this study, there have been new 
reviews of the evidence, with similar 
findings:15,16 for example, in a review and 
meta-analysis published in 2017, lowering 
systolic BP by 10 mmHg was associated with 
7% reduction in all-cause mortality, 15% 
reduction in cardiovascular mortality, 22% 
How this fits in
There are a number of effective models of 
care for the management of hypertension, 
including GP led, pharmacist led, telehealth, 
and self-management. Treatment decisions 
should prioritise effectiveness along 
with patient preferences through shared 
decision-making. This study used a discrete 
choice experiment to investigate patient 
preferences for hypertension management, 
and found that patients prioritise reduction 
in cardiovascular risk. When offering new 
models of care, it is important to discuss 
the outcomes in terms of risk and risk 
reduction, and this may have an impact on 
the ‘buy-in’ among patients.
Box 1. What is a discrete choice experiment? 
A discrete choice experiment (DCE) is a technique for eliciting preferences that provides information about 
the way individuals value different attributes of health, as well as the potential demand for new programmes, 
services, or treatments. DCEs are based on the assumption that healthcare interventions/services can be 
described by their characteristics (or attributes), and that an individual’s valuation depends on the levels of 
the attributes. It is also assumed that individuals behave rationally and make choices that maximise their 
satisfaction (or utility in economics terminology).
In a DCE participants are presented with a series of questions where they are asked to choose between 
hypothetical alternatives, each with differing levels of the attributes being tested. In the example below an 
individual is asked to choose between two chocolate bars (A and B), which are described by five attributes 
(cocoa content, price, size and so on. Each attribute will have a number of potential options or levels.
Which chocolate bar would you prefer?
 Chocolate bar A Chocolate bar B
Cocoa content 25% (milk chocolate) 60% (dark chocolate)
Added ingredients Almonds, raisins None
Fairtrade? No Yes
Size 60 g 75 g
Cost £1.00 £1.25
I would prefer:
• Chocolate bar A
• Chocolate bar B
• Neither 
By asking a number of questions in which the levels of the attributes are different, a picture of the strength 
of preferences for each attribute and level can be built. One is able to investigate the importance that 
individuals place on different aspects of a product/service, and the extent to which they are willing to make 
trade-offs between those aspects; for example, the increase/decrease in cost related to the chocolate bar 
being Fairtrade. When costs are included, DCEs can estimate the ‘willingness-to-pay’ of particular product/
services/changes in attributes.
The information from a DCE can be used to infer what is important to individuals when making choices in 
health. It is also possible to estimate the likelihood that individuals would choose a new service and their 
willingness to pay; vital information when commissioning new services. 
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reduction in major cardiovascular events, 
31% reduction in stroke, and 47% reduction 
in heart failure.16 Different models of care, 
with different frequencies of feedback on 
the results of treatment, and less frequent 
contact with healthcare providers, have the 
potential to result in different reductions in 
cardiovascular disease risk (due to different 
patterns of medication adherence and 
medication prescribing).
Costs. It is estimated that diseases caused 
by hypertension cost the NHS £2 billion 
every year.17 Cost was framed as cost to the 
NHS. The cost levels included were based 
on the costs of healthcare providers’ time, 
as reported in the Unit Costs of Health and 
Social Care.18 
Study design and questionnaire
The DCE presented participants with 
sets of hypothetical models of care for 
hypertension that differed according to 
the levels assigned to the four attributes 
of interest. Two alternatives (A and B) 
were presented in each choice set. A full 
factorial design includes all of the possible 
combinations of the levels and attributes. 
Given four attributes each with four levels, 
the full factorial design for one set of 
choices would be 44 (256); and in a pairwise 
DCE, where two alternatives are presented, 
the total number of possible pairs would be 
32 640 (that is, 256*255/2). 
An orthogonal main effects plan with a 
shifted design was used to create a choice 
set with 16 choice questions. The final 
design allowed for the identification of all 
main effects and had 95.5% D-efficiency.
The DCE survey was developed using 
the open source survey tool LimeSurvey 
(www.limesurvey.org), and administered 
online. The online survey incorporating 
the DCE comprised screening questions; 
choice questions (x16), demographics, and 
feedback. The final position of each option 
within each choice (that is, A versus B; B 
versus A), and the position of each choice 
(1–16) were assigned randomly for each 
participant.
Box 2. Attributes and levels included in discrete choice experiment 
Attribute Level
Model of care  GP led — you schedule an appointment during normal clinic hours at 
your local general practice. Your BP is measured and any necessary 
changes to your medication are made by your GP.
  Pharmacist led  — you attend a walk-in service (no appointment 
required) at your local pharmacy. Your BP is measured by the pharmacist, 
and medication changes are made by the pharmacist in accordance with 
plan made by you and your GP.
  Telehealth — you measure your BP at home using an automated BP 
device which automatically transmits the results to your GP. Your GP will 
review the measurements you made to make any necessary changes to 
your medication. You will not have to schedule any clinic appointments for 
your BP as long as it remains controlled.
  Self-management — you measure your BP at home using an automated 
BP device. You are responsible for making any necessary medication 
changes, according to a protocol agreed beforehand with your GP.
Frequency of measurement Every month
 Every 3 months
 Every 6 months
 Every 12 months
Risk  By using this service, you will be 5% less likely to have a stroke or heart 
attack in the next 5 years
  By using this service, you will be 10% less likely to have a stroke or heart 
attack in the next 5 years
  By using this service, you will be 15% less likely to have a stroke or heart 
attack in the next 5 years
  By using this service, you will be 25% less likely to have a stroke or heart 
attack in the next 5 years
Annual cost to the NHS £50 
 £100
 £250
 £500
BP = blood pressure. 
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Sample size consideration
Sample size was calculated using the 
‘rule of thumb’ method proposed by 
Johnson and Orme for DCEs without prior 
information, which estimated that at least 
100 participants would be required.19,20 
Simulation was conducted to understand 
whether the parameters of the models 
were estimable for different sample sizes, 
and confirmed the experimental design was 
robust with sample size n >100.
Participants and data collection
A database of patients who registered 
interest in taking part in research was used 
to recruit participants. ‘Research for the 
Future’ is an NHS-supported campaign 
to encourage people to take part in health 
research opportunities and includes Help 
BEAT Diabetes, Help BEAT Respiratory 
Disease, and Help BEAT Heart Disease. An 
email was sent to all registered patients, 
and adults with a self-reported diagnosis of 
hypertension were invited to take part.
Data analysis
Participant demographics were 
summarised using descriptive statistics.
A full description of statistical methods 
is available from the author on request. 
DCE data were analysed using a random 
parameter mixed logit model. These results 
were used to conduct a post-estimation 
scenario analysis to investigate what the 
predicted uptake of different models of care 
would be if all were available to patients 
(that is, what was the value that patients 
place on each model of care). The predicted 
probabilities that patients would choose 
each model of care was estimated assuming 
participants had access to all four, and 
all else being equal (in this case all other 
attributes set to the baseline category). 
Also assessed was the impact that single 
level changes have on overall predicted 
uptake (change in the predicted uptake 
if the frequency of BP measurements at 
the GP practice increased from monthly to 
three times a month, was estimated).21 The 
impact of level changes in overall predicted 
uptake for the three attributes other than 
model of care in the DCE was evaluated, 
and these results are presented using the 
absolute change in predicted uptake from 
baseline and associated 95% confidence 
intervals (CIs). All analyses were conducted 
using Stata (version14).
RESULTS
Participant characteristics
An invitation to take part was emailed to 
2761 individuals, and between 3–20 June 
2016, 263 people opened the link to the 
questionnaire. Of those who opened the 
link, 42 (16%) were not eligible (that is, did 
not have hypertension, or were <18 years 
old). One hundred and sixty-seven of the 221 
eligible participants who opened the link 
completed the questionnaire (76%). Fifty-
four (24%) completed at least one choice 
question, but did not finish the questionnaire, 
and were excluded from the analysis. 
Responder characteristics are shown in 
Table 1. Mean age was 61.4 years and 45.0% 
were women. The majority (82.0%) had a 
diagnosis of hypertension for >5 years, and 
took an average of two BP medications. 
The majority of the responders (n = 160) 
Table 1. Participant demographics 
 Participants, n = 167
Female, n (%) 75 (45.0)
Age, years, mean (SD) 61.4 (9.9)
Age range, years 25–84
Years since diagnosis with hypertension,b n (%) 
<1 years 10 (6.1)
1–5 years 20 (12.3)
>5 years 133 (82.0)
Measure own BP at home, n (%) 86 (52.0)
Number of medications for hypertension, mean (SD) 1.76 (1.06)
Number of medications for other conditions, mean (SD) 4.79 (3.06)
Ethnicity,b n (%) 
White 160 (97.0)
Mixed/multiple ethnic groups 1 (0.6)
Asian/Asian British 3 (1.8)
Black/African/Caribbean/Black British 1 (0.6)
Other/rather not say 0 (0.0)
Index of Multiple Deprivation score, mean (SD) 19.6 (17.1)
Deprivation from postcode, quintiles 1–5,a,b n (%) 
1 44 (30.1)
2  34 (23.3)
3 18 (12.3)
4 24 (16.4)
5 26 (17.8)
Highest level of education,b n (%) 
GCSE/O level or equivalent (left school aged 16 years) 39 (24.1)
A level or equivalent (left school at aged 18 years) 17 (10.5)
Vocational (NVQ) 18 (11.1)
University 79 (49.0)
Other/rather not say 9 (5.5)
Employment,b n (%) 
Full-time employment 36 (22.2)
Part-time employment 21 (12.9)
Homemaker looking after family 3 (1.9)
Student in full-time education  0 (0.0)
Retired 99 (61.1)
Unemployed 3 (1.9)
aAccording to Multiple Deprivation Score, 1 is least deprived. bDemographic questions were not mandatory and 
there were some missing data where responders chose not to answer. BP = blood pressure. NVQ = National 
Vocational Qualification. SD = standard deviation.  
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described themselves as white (97.0%), 
over half were retired (61.1%), and around 
half reported university as their highest 
level of education (49.0%). Half (52.0%) of 
responders reported measuring their BP 
at home. According to the Index of Multiple 
Deprivation score, participants lived in areas 
evenly spread across quintiles.
Patient preferences for hypertension 
model of care
Results from the random parameter mixed 
logit model are presented in Table 2. All 
attributes have at least one significant 
difference between levels indicating that 
all played an important part in decision-
making. The coefficient for cost was 
negative and significant indicating that 
responders preferred scenarios that cost 
less to the NHS. Within model of care, 
all coefficients were negative, indicating 
that GP management (the reference 
category) was preferred to all other options, 
although only the coefficient for self-
management was statistically significant. 
For frequency of BP measurement, the 
trend was towards preference for more 
frequent BP measurement, with 6-monthly 
and annual BP measurement having 
significant negative coefficients. Reduction 
in cardiovascular risk was a significant 
driver of preferences, with participants 
preferring increased reduction in 5-year 
cardiovascular risk. All of the coefficients 
were positive and statistically significant.
Statistically significant standard deviations 
were observed for all of the levels in model 
of care, for 25% reduction in cardiovascular 
Table 2. Parameter coefficients from the random parameter mixed 
logit model
Parameters
Variable Coefficient 95% CI P-value
Model of care (reference category GP) [0]
Pharmacist –0.094 –0.291 to 0.104 0.353
Telehealth –0.191 –0.421 to 0.039 0.103
Self–management –0.306 –0.597 to –0.015 0.039
Frequency of BP measurement (monthly) [0]
Every 3 months –0.079 –0.265 to 0.107 0.406
Every 6 months –0.231 –0.440 to –0.022 0.030
Annually  –0.837 –1.017 to –0.658 <0.001
Reduction in 5-year CV risk (5%) [0]
10% 1.083 0.888 to 1.278 <0.001
15% 1.099 0.879 to 1.319 <0.001
25% 1.863 1.599 to 2.128 <0.001
Cost to NHS, £ –6.167 –6.424 to –5.911 <0.001
Standard deviations
Variable Coefficient SE P-value
Model of care (reference category GP) [0]
Pharmacist 0.684 0.119 <0.001
Telehealth 0.692 0.149 <0.001
Self–management 1.587 0.159 <0.001
Frequency of BP measurement (monthly) [0]
Every 3 months 0.021 0.107 0.848
Every 6 months 0.071 0.116 0.538
Annually  0.076 0.151 0.615
Reduction in 5-year CV risk (5%) [0]
10% 0.106 0.129 0.410
15% 0.091 0.144 0.526
25% 1.037 0.135 <0.001
Cost to NHS, £ 0.910 0.094 <0.001
Goodness of fit
Number of observations 5344  
Number of choices 2672  
Log likelihood –1432  
BP = blood pressure. CV = cardiovascular. SE = standard error.
e633  British Journal of General Practice, September 2019 
disease risk, and for the cost attribute. 
This indicated that for these attributes/
levels there was considerable random 
(unexplained) variation across participants. 
Exploratory analyses indicated that age 
may account for some of the heterogeneity 
within model of care (that is, younger 
versus older having different preferences); 
however, results were inconclusive (further 
information is available from the author on 
request).
Trade-offs between attributes were 
calculated in terms of cost, to determine 
how much participants were willing to pay, 
and results are presented in Table 3. All 
else being equal, participants were willing 
to pay (that is the cost to the NHS) £374.74, 
£398.98, and £673.45 for 10%, 15%, and 
25% reduction in 5-year cardiovascular 
disease risk, respectively. Willingness to pay 
for annual BP measurement was –£247.90 
reflecting the negative preference for this 
attribute level (conversely this can be 
interpreted as participants being willing to 
pay £247.90 for monthly BP measurement 
over annual measurement). 
Post-estimation scenario analysis
The impact of single level changes to 
attributes (all else being equal) on uptake of 
different models of care were investigated, 
and these results are shown in Table 4. 
For example, changing the reduction in 
5-year cardiovascular disease risk from 
5% to 10% increased uptake of GP 
management by 21.5% (95% CI = 11.5 to 
31.6). Similarly, changing the reduction 
in 5-year cardiovascular disease risk by 
the same level for self-management was 
associated with an increase in uptake of 
Table 3. Willingness to pay
Parameters
Variable Coefficient 95% CI P-value
Model of care (reference category GP) [0]
Pharmacist 20.19 –52.24 to 92.62 0.585
Telehealth –48.02 –126.08 to 30.04 0.228
Self–management –70.52 –170.95 to 29.91 0.169
Frequency of BP measurement (monthly) [0]
Every 3 months –4.90 –74.79 to 65.00 0.891
Every 6 months –67.48 –145.79 to 10.44 0.090
Annually  –247.90 –318.71 to –177.08 <0.001
Reduction in 5-year CV risk (5%) [0]
10% 374.74 297.80 to 451.69 <0.001
15% 398.98 308.43 to 489.52 <0.001
25% 673.45 561.70 to 785.20 <0.001
Cost to NHS, £ –5.87 –6.05 to –5.69 <0.001
Standard deviations
Variable Coefficient SE P-value
Model of care (reference category GP) [0]
Pharmacist 219.68 38.18 <0.001
Telehealth 71.99 46.73 0.123
Self–management 514.25 60.40 0.000
Frequency of BP measurement (monthly) [0]
Every 3 months 8.46 31.18 0.791
Every 6 months 8.63 30.73 0.779
Annually  43.39 32.02 0.175
Reduction in 5-year CV risk (5%) [0]
10% 62.04 35.84 0.083
15% 4.65 31.77 0.884
25% 278.10 41.87 <0.001
Cost to NHS, £ 0.665 0.106 <0.001
Goodness of fit
Number of observations 5344
Number of choices 2672
Log likelihood –1451
BP = blood pressure. CV = cardiovascular. SE = standard error. 
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18.9% (95% CI = 8.8 to 28.9). Increases in 
the frequency of BP measurement were 
associated with increases in predicted 
uptake. Increases in cost were associated 
with decreases in predicted uptakes. 
DISCUSSION
Summary
This study appears to be the first time a 
DCE has been conducted to investigate 
patient preferences for the management 
of hypertension. All attributes included in 
the experiment had at least one significant 
level in the mixed logit analysis indicating 
that they were all important with regards to 
patient preferences. There was no evidence 
of a difference in patient preferences for GP 
management, pharmacist management, or 
telehealth, while there was evidence that 
participants preferred GP management 
over self-management. Patients preferred 
scenarios that had greater reduction in 
cardiovascular risk, more frequent BP 
monitoring, and lower costs. Risk was 
the most important driver of choice as 
evidenced by both the scenario analysis and 
the marginal willingness-to-pay analysis.
Strengths and limitations
This was an experimental study and 
participant choices may not represent how 
individuals behave in real-world situations. 
As three of the models of care were not 
available routinely to patients in the UK, 
an experimental approach was the only 
way of determining how patients may 
make choices about the management of 
hypertension. The GP-led care model may 
also not represent the ‘usual care’ option 
for some, as care is often provided by 
practice nurses in England. As mentioned 
previously, the direction of effects for risk 
(choosing greater risk reduction) and cost 
(choosing lower cost), combined with the 
fact that all four attributes were important 
in decision-making, provide evidence that 
participants engaged with the choice tasks 
and that the choices were appropriate. To 
validate the findings requires observation of 
actual choices, and until all of the options 
included here are routinely available, this 
will be difficult.
A strength of DCEs in general is that 
they present information to participants that 
resembles real-world decisions; that is, to 
say that decisions are based on a number 
of different, and sometimes competing, 
priorities. This analysis represents average 
preferences across participants, and there 
was evidence of heterogeneity, particularly 
in the model of care attribute. Therefore, 
there is a need to recognise that not all 
patients want the same thing, and further 
research should focus on investigating 
groups of patients with similar preferences.
Care should be taken in interpreting the 
results beyond the included sample. The 
final sample was well educated and almost 
all participants described themselves as 
white. This reflects the challenge across 
research studies in recruiting participants 
from minority groups. Future studies should 
Table 4. Comparison of change in predicted probabilities for each model of care in response to changes in 
selected attributes
  GP Pharmacist Telehealth Self-management
Baseline uptake, % (95% CI)a 25.7 (22.0 to 28.3) 24.8 (21.1 to 27.7) 23.3 (19.2 to 26.4) 26.2 (23.4 to 32.8)
Change in probability from baseline, % (95% CI)b
Attribute Change    
Frequency of BP measurement 
 Monthly to every 3 months  –2.5 (–11.7 to 6.7) –1.5 (–10.7 to 7.6) –2.6 (–11.5 to 6.3) 0.0 (–9.4 to 9.5)
 Monthly to every 6 months –4.7 (–13.7 to 4.4) –4.4 (–13.4 to 4.5) –3.9 (–12.6 to 4.9) –1.8 (–11.1 to 7.6)
 Monthly to every 12 months –12.7 (–21.0 to 4.3) –11.9 (–20.2 to 3.6) –10.9 (–19.0 to 2.8) –9.5 (–18.2 to 0.7)
Reduction in 5-year cardiovascular risk 
 5% to 10% 21.5 (11.5 to 31.6) 20.9 (10.9 to 30.9) 20.2 (10.4 to 30.1) 18.9 (8.8 to 28.9)
 5% to 15% 22.0 (11.9 to 32.0) 21.9 (11.9 to 31.9) 19.9 (10.0 to 29.8) 17.3 (7.3 to 27.4) 
 5% to 25% 34.1 (24.2 to 44.1) 35.1 (25.1 to 45.0) 34.2 (24.3 to 44.1) 32.1 (22.1 to 42.1)
Cost to NHS  
 £50 to £100 –2.9 (–12.1 to 6.3) –1.1 (–10.3 to 8.1) –2.8 (–11.7 to 6.0) –0.3 (–9.7 to 9.1)
 £50 to £150 –6.9 (–15.8 to 2.0) –8.7 (–17.3 to 0.1) –7.0 (–15.5 to 1.5) –5.7 (–14.7 to 3.4)
 £50 to £250 –14.3 (–22.5 to–6.1) –13.6 (–21.7 to –5.5) –14.0 (–21.8 to –6.2) –10.8 (–19.4 to –2.2)
aBaseline uptake represents the predicted probabilities that participants would choose each model of care assuming participants had access to all four, all else being equal. 
bRefers to change from baseline uptake and represents absolute change in proportions. BP = blood pressure.
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target minority groups, as these groups often 
have the worse cardiovascular outcomes.
Comparison with existing literature 
Previous research into self-monitoring, 
telehealth, and new models of care has 
shown that patients are willing to engage, 
and that these can be clinically effective. This 
study provides evidence that patients in the 
general population are willing to consider 
change.10,22,23 Based on research evidence, 
some of these new ways of managing 
hypertension are being introduced into 
usual care. In the UK the majority of patients 
are now likely to measure their own BP at 
home and to discuss this with their GPs, 
and GPs are more comfortable using these 
measures to guide treatment.24 Since the 
inception of this study, NHS England has 
invested significantly in a pilot of practice-
based pharmacists.25 This study included 
community pharmacy as an option, as 
interviews showed that patients found 
visits to the pharmacy more convenient 
(more options locally, often closer to 
home, and able to visit without the need 
to make an appointment). Management of 
hypertension is one option where practice-
based pharmacists could be engaged. 
However, it is worth noting that 
participants in this survey had a negative 
preference for self-management. It might 
be the case that patients are willing to 
become more involved in their care up to 
a point, but are wary of too much change. 
This preference may shift over time as 
patients become more used to being more 
involved in their care. Patients in trials of 
self-management have reported positive 
experiences; however, may have been 
asked to reflect on their experience, rather 
than their concerns before beginning.
Implications for practice
Participants prioritised services that 
reduced their cardiovascular risk. Scenario 
analysis showed that when the outcome 
changed from lowest to highest risk 
reduction category, the likelihood that 
participants would choose a model of care 
doubled. When offering new models of care, 
it is important to discuss the outcomes 
in terms of risk and risk reduction, and 
this may have an impact on the ‘buy-in’ 
among patients. In a policy environment 
that promotes patient choice, DCEs are 
a promising method for investigating 
preferences, and modelling future demand 
when commissioning new services.
This study investigated patient 
preferences for the management of 
hypertension and found a number of factors 
that were important. Participants had 
similar preferences for GP management, 
pharmacist management, and telehealth, 
but a negative preference for self-
management. When introducing new 
models of care for hypertension to patients, 
discussion of the potential benefits in terms 
of risk reduction should be prioritised to 
maximise uptake.
British Journal of General Practice, September 2019  e636
REFERENCES
1. NHS Digital. Health Survey for England. 2017. https://digital.nhs.uk/data-and-
information/publications/statistical/health-survey-for-england/2017 (accessed 
1 Aug 2019).
2. National Institute for Health and Care Excellence. Guideline. Hypertension in 
adults: diagnosis and management. Draft for consultation, March 2019. https://
www.nice.org.uk/guidance/gid-ng10054/documents/draft-guideline (accessed 
1 Aug 2019).
3. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients 
with chronic illness. JAMA 2002; 288(14): 1775–1779.
4. Uhlig K, Patel K, Ip S, et al. Self-measured blood pressure monitoring in the 
management of hypertension: a systematic review and meta-analysis. Ann 
Intern Med 2013; 159(3): 185–194.
5. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost 
effectiveness of home blood pressure telemonitoring: meta-analysis of 
randomized controlled studies. J Hypertens 2013; 31(3): 455–467; discussion 
67–68.
6. Clark CE, Smith LFP, Taylor RS, Campbell JL. Nurse led interventions to 
improve control of blood pressure in people with hypertension: Systematic review 
and meta-analysis. BMJ 2010; 341: c3995.
7. Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control 
through pharmacist interventions: a meta-analysis of randomized controlled 
trials. J Am Heart Assoc 2014; 3(2): e000718.
8. McManus RJ, Mant J, Franssen M, et al. Efficacy of self-monitored blood 
pressure, with or without telemonitoring, for titration of antihypertensive 
medication (TASMINH4): an unmasked randomised controlled trial. Lancet 2018; 
391(10124): 949–959.
9. Clark MD, Determann D, Petrou S, et al. Discrete choice experiments in health 
economics: a review of the literature. Pharmacoeconomics 2014; 32(9): 883–902.
10. Fletcher BR, Hinton L, Hartmann-Boyce J, et al. Self-monitoring blood pressure 
in hypertension, patient and provider perspectives: A systematic review and 
thematic synthesis. Patient Educ Couns 2016; 99(2): 210–219.
11. National Institute for Health and Care Excellence. Hypertension in adults: 
diagnosis and management. Clinical guideline [CG127]. 2011. https://www.nice.
org.uk/guidance/cg127 (accessed 1 Aug 2019).  
12. National Services Scotland. Practice Team Information (PTI) annual update 
(2012/2013). National Statistics Publication for Scotland 2013. https://www.
isdscotland.org/Health-Topics/General-Practice/Publications/2013-10-29/2013-
10-29-PTI-Report.pdf (accessed 1 Aug 2019). 
13. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood 
pressure to vascular mortality: a meta-analysis of individual data for one million 
adults in 61 prospective studies. Lancet 2002; 360(9349): 1903–1913.
14. Turnbull F. Effects of different blood-pressure-lowering regimens on major 
cardiovascular events: results of prospectively-designed overviews of 
randomised trials. Lancet 2003; 362(9395): 1527–1535.
15. Brunstrom M, Carlberg B. Association of blood pressure lowering with mortality 
and cardiovascular disease across blood pressure levels: a systematic review 
and meta-analysis. JAMA Intern Med 2018; 178(1): 28–36.
16. Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of 
cardiovascular disease and mortality: a systematic review and network meta-
analysis. JAMA Cardiol 2017; 2(7): 775–781.
17. Public Health England. New figures show high blood pressure costs NHS 
billions each year. https://www.gov.uk/government/news/new-figures-show-
high-blood-pressure-costs-nhs-billions-each-year (accessed 1 Aug 2019).
18. Curtis L, Burns A. Unit costs of health and social care 2015. 2015. https://www.
pssru.ac.uk/project-pages/unit-costs/unit-costs-2015/ (accessed 1 Aug 2019).
19. de Bekker-Grob EW, Donkers B, Jonker MF, Stolk EA. Sample size 
requirements for discrete-choice experiments in healthcare: a practical guide. 
Patient 2015; 8(5): 373–384.
20. Johnson R, Orme B. Getting the most from CBC. Sawtooth Software Research 
Paper Series 2003. https://www.sawtoothsoftware.com/download/techpap/
cbcmost.pdf (accessed 1 Aug 2019).
21. Lancsar E, Fiebig DG, Hole AR. Discrete choice experiments: a guide to model 
specification, estimation and software. Pharmacoeconomics 2017; 35(7): 
697–716.
22. Hanley J, Pinnock H, Paterson M, McKinstry B. Implementing telemonitoring in 
primary care: learning from a large qualitative dataset gathered during a series 
of studies. BMC Fam Pract 2018; 19(1): 118.
23. Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the 
pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens 
(Greenwich) 2012; 14(1): 51–65.
24. Fletcher BR, Hinton L, Bray EP, et al. Self-monitoring blood pressure in patients 
with hypertension: an internet-based survey of UK GPs. Br J Gen Pract 2016; 
DOI: https://doi.org/10.3399/bjgp16X687037.
25. NHS England. Clinical pharmacists in general practice. https://www.england.
nhs.uk/gp/gpfv/workforce/building-the-general-practice-workforce/cp-gp/ 
(accessed 1 Aug 2018).
e637  British Journal of General Practice, September 2019 
